Effect of Anti-gravity Treadmill Training After Total Hip Arthroplasty

NCT ID: NCT07170215

Last Updated: 2025-09-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-15

Study Completion Date

2023-07-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background/Objectives: Total hip arthroplasty is one of the most common orthopedic procedures. When the surgery is successful and followed by high-quality physiotherapy, patients' quality of life usually improves and they return to their daily activities more qui-ckly.. Rehabilitation methods and medical devices are constantly evolving, to accelerate functional improvement. The aim of the study is to investigate the impact of the antigra-vity treadmill on the functional outcomes after total hip arthroplasty. Methods: A single centre, randomised, controlled, open label trial was conduct in Hospital for Medical Re-habilitation of the Heart and Lung Diseases and Rheumatism Thalassotherapia Opatija. 34 subjects were randomly divided into two groups: experimental (18) and control (16). The outcome measures included strength of the abductor muscles, range of motion, visual analogue scale, and Timed Up and Go test and 40-meter Fast Paced Walk test.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Osteoarthritis, Hip

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Patients were randomly assigned to one of two groups: the experimental group (EG) (n = 18) received antigravity treadmill therapy in combination with a standard rehabilita-tion protocol and the control group (CG) (n = 16) followed only the conventional rehabili-tation protocol.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Masking was not possible.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

experimental group (EG)

Each session included 25 minutes of individualized therapeutic exercises focused on bre-athing, mobility, strength, and balance. In addition, participants received 25 minutes of electrical stimulation of the quadriceps femoris muscle and 25 minutes of hydrotherapy in a swimming pool, for a total of 75 minutes of therapy per session. The experimental group (EG) also completed 20 minutes of daily exercise on an antigravity treadmill (ALTERG VIA, Lifeward CA, Inc., Milmont Drive, Fremont, CA, USA), supervised by a physiothera-pist

Group Type EXPERIMENTAL

antigravity treadmill (ALTERG VIA, Lifeward CA, Inc., Milmont Drive, Fremont, CA, U-SA)

Intervention Type DEVICE

Antigravity treadmill training in the experimental group (EG) involved walking in a straight line at a self-selected, com-fortable pace-without running, shortness of breath, or pain. The treadmill's chamber was set to reduce the participant's effective body weight to 20% of their actual body weight (slight unloading was applied to reduce the need for handrail support and to prevent the use of compensatory mechanisms).

control group (CG)

Each session inclu-ded 25 minutes of individualized therapeutic exercises focused on breathing, mobility, strength, and balance. In addition, participants received 25 minutes of electrical stimula-tion of the quadriceps femoris muscle and 25 minutes of hydrotherapy in a swimming pool, for a total of 75 minutes of therapy per session.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

antigravity treadmill (ALTERG VIA, Lifeward CA, Inc., Milmont Drive, Fremont, CA, U-SA)

Antigravity treadmill training in the experimental group (EG) involved walking in a straight line at a self-selected, com-fortable pace-without running, shortness of breath, or pain. The treadmill's chamber was set to reduce the participant's effective body weight to 20% of their actual body weight (slight unloading was applied to reduce the need for handrail support and to prevent the use of compensatory mechanisms).

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Inclusion Criteria:

* The inclusion criteria was primary osteoarthritis of the hip joint.

Exclusion Criteria:

* Exclusion criteria included: Undergoing surgery using a different technique, revision hip replacement, acute illness, cognitive impairment, and declining participation in the study.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Rijeka

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Mirela Vuckovic

Assist. prof

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Thalassotherapia Opatija

Rijeka, , Croatia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Croatia

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

THR-2025

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PT vs no PT Following THA
NCT02687945 COMPLETED NA